Systematic Analysis Reveals That Common Mitochondrial Disease Causing-M.14487T>C Mutation is Insufficient to Cause Mitochondrial Deficiency

Qiongya Zhao,Miaomiao Du,Deyu Chen,Jingting Xiong,Xiujuan Wei,Jie Xie,Xueyun Li,Qinxia Han,Huaibin Zhou,Lijun Shen,Yanling Yang,Hezhi Fang,Jianxin Lyu
DOI: https://doi.org/10.2139/ssrn.3422981
2019-01-01
Abstract:Background: The m.14487T>C mutation is recognized as a diagnostic mutation of mitochondrial disease during the past 16 years, emerging evidence suggests that mutant loads of m.14487T>C and disease phenotype are not closely correlated.Methods: Immortalized lymphocytes were generated by Co-culturing the Epstein-Barr virus and lymphocytes from m.14487T>C-carrier-Chinese patient with Leigh syndrome. 15 cytoplasmic hybrid (cybrid) cell lines were generated by fusing mtDNA lacking 143B cells with platelets donated by patients. Mitochondrial function was systematically analyzed at transcriptomic, metabolomic, and biochemical level.Findings: Unlike previous reports, we found that the assembly of mitochondrial respiratory chain complexes, mitochondrial respiration, and mitochondrial OXPHOS function was barely affected in cybrid cells carrying homoplastic m.14487T>C mutation. Mitochondrial dysfunction associated transcriptomic and metabolomic reprogramming were not detected in cybrid carrying homoplastic m.14487T>C. However, we found that mitochondrial function was impaired in patient-derived immortalized lymphocytes.Interpretation: Our data revealed that m.14487T>C mutation is insufficient to cause mitochondrial deficiency; additional modifier genes may be involved in m.14487T>C associated mitochondrial disease. Our results further demonstrated that a caution should be taken by solely use of m.14487T>C mutation for molecular diagnosis of mitochondrial disease.Funding Statement: This research was supported by the National Natural Science Foundation of China (key program, 81830071; emergency program, 81741061), the Key Discipline of Zhejiang Province in Medical Technology (First Class, Category A); Zhejiang Provincial Natural Science Foundation of China (LY19H040004). National Key Research and Development Program of China (Grant No. 2017YFC1001700). Declaration of Interests: The authors declare that there is no conflict of interest.Ethical Approval Statement: Informed consent was obtained from all three subjects under protocols approved by the Ethical Committee of the Peking University First Hospital, and the ID of the Ethics Committee is 2017-217. All experimental methods were carried out according to the approved guidelines of the Peking University First Hospital.
What problem does this paper attempt to address?